Fulgent Genetics (FLGT) Competitors $19.77 +0.20 (+1.02%) (As of 11:57 AM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends FLGT vs. ADUS, WGS, TDOC, NHC, FTRE, VRDN, CDNA, AHCO, AVAH, and PNTGShould you be buying Fulgent Genetics stock or one of its competitors? The main competitors of Fulgent Genetics include Addus HomeCare (ADUS), GeneDx (WGS), Teladoc Health (TDOC), National HealthCare (NHC), Fortrea (FTRE), Viridian Therapeutics (VRDN), CareDx (CDNA), AdaptHealth (AHCO), Aveanna Healthcare (AVAH), and The Pennant Group (PNTG). These companies are all part of the "healthcare" industry. Fulgent Genetics vs. Addus HomeCare GeneDx Teladoc Health National HealthCare Fortrea Viridian Therapeutics CareDx AdaptHealth Aveanna Healthcare The Pennant Group Addus HomeCare (NASDAQ:ADUS) and Fulgent Genetics (NASDAQ:FLGT) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, community ranking, valuation, profitability, dividends, analyst recommendations, earnings, institutional ownership and risk. Does the MarketBeat Community believe in ADUS or FLGT? Addus HomeCare received 76 more outperform votes than Fulgent Genetics when rated by MarketBeat users. Likewise, 68.67% of users gave Addus HomeCare an outperform vote while only 60.10% of users gave Fulgent Genetics an outperform vote. CompanyUnderperformOutperformAddus HomeCareOutperform Votes32068.67% Underperform Votes14631.33% Fulgent GeneticsOutperform Votes24460.10% Underperform Votes16239.90% Does the media favor ADUS or FLGT? In the previous week, Addus HomeCare and Addus HomeCare both had 8 articles in the media. Addus HomeCare's average media sentiment score of 1.12 beat Fulgent Genetics' score of 0.29 indicating that Addus HomeCare is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Addus HomeCare 4 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Fulgent Genetics 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Is ADUS or FLGT more profitable? Addus HomeCare has a net margin of 6.50% compared to Fulgent Genetics' net margin of -59.39%. Addus HomeCare's return on equity of 9.62% beat Fulgent Genetics' return on equity.Company Net Margins Return on Equity Return on Assets Addus HomeCare6.50% 9.62% 7.37% Fulgent Genetics -59.39%-1.81%-1.66% Do institutionals and insiders hold more shares of ADUS or FLGT? 95.4% of Addus HomeCare shares are held by institutional investors. Comparatively, 48.1% of Fulgent Genetics shares are held by institutional investors. 4.6% of Addus HomeCare shares are held by company insiders. Comparatively, 32.7% of Fulgent Genetics shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Which has better earnings and valuation, ADUS or FLGT? Addus HomeCare has higher revenue and earnings than Fulgent Genetics. Fulgent Genetics is trading at a lower price-to-earnings ratio than Addus HomeCare, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAddus HomeCare$1.06B2.10$62.52M$4.3728.05Fulgent Genetics$289.21M2.09-$167.82M-$5.52-3.58 Which has more risk and volatility, ADUS or FLGT? Addus HomeCare has a beta of 1.02, indicating that its stock price is 2% more volatile than the S&P 500. Comparatively, Fulgent Genetics has a beta of 1.42, indicating that its stock price is 42% more volatile than the S&P 500. Do analysts prefer ADUS or FLGT? Addus HomeCare currently has a consensus target price of $131.63, suggesting a potential upside of 7.36%. Fulgent Genetics has a consensus target price of $28.50, suggesting a potential upside of 44.16%. Given Fulgent Genetics' higher probable upside, analysts clearly believe Fulgent Genetics is more favorable than Addus HomeCare.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Addus HomeCare 1 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 2.89Fulgent Genetics 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 SummaryAddus HomeCare beats Fulgent Genetics on 15 of the 18 factors compared between the two stocks. Ad Porter & CompanyThis company will win the AI race Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally critical role in supporting the most revolutionary technology the world’s ever seen… artificial intelligence. And without it, the entire AI industry would collapse. You must read this new presentation from Porter Stansberry. Get Fulgent Genetics News Delivered to You Automatically Sign up to receive the latest news and ratings for FLGT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FLGT vs. The Competition Export to ExcelMetricFulgent GeneticsMedical laboratories IndustryMedical SectorNASDAQ ExchangeMarket Cap$604.76M$3.21B$5.20B$8.97BDividend YieldN/A10.51%5.23%4.04%P/E Ratio-3.5810.1585.7113.39Price / Sales2.09232.271,469.4286.49Price / Cash5.63464.8835.2935.09Price / Book0.525.234.914.96Net Income-$167.82M-$32.86M$117.36M$224.10M7 Day Performance10.51%5.05%2.75%2.01%1 Month Performance-8.51%8.48%1.71%9.79%1 Year Performance-28.03%23.83%36.01%29.97% Fulgent Genetics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FLGTFulgent Genetics4.6389 of 5 stars$19.77+1.0%$28.50+44.2%-28.8%$604.76M$289.21M-3.581,184Short Interest ↓ADUSAddus HomeCare4.7458 of 5 stars$123.16+0.3%$131.63+6.9%+37.4%$2.23B$1.06B28.0234,846Positive NewsWGSGeneDx1.6325 of 5 stars$76.13-2.9%$59.33-22.1%+4,191.1%$2.09B$267.23M-25.221,200Positive NewsTDOCTeladoc Health2.3113 of 5 stars$11.60-3.2%$12.08+4.1%-39.4%$2.00B$2.59B-2.105,600Positive NewsNHCNational HealthCareN/A$127.20+1.6%N/AN/A$1.96B$1.23B15.7513,123FTREFortrea3.1287 of 5 stars$21.59+2.6%$24.50+13.5%-30.1%$1.94B$3.11B-6.1518,000VRDNViridian Therapeutics3.4732 of 5 stars$21.33-1.0%$36.33+70.3%+22.0%$1.69B$302,000.00-4.9250Positive NewsCDNACareDx3.6108 of 5 stars$25.57+4.2%$29.60+15.8%+159.5%$1.37B$280.32M-9.09740Short Interest ↓Positive NewsAHCOAdaptHealth3.6188 of 5 stars$10.05+0.2%$11.67+16.1%+13.7%$1.35B$3.20B-6.0810,700Positive NewsAVAHAveanna Healthcare1.4056 of 5 stars$5.87+1.0%$4.27-27.3%+115.1%$1.13B$1.98B-17.1533,500Short Interest ↓Positive NewsPNTGThe Pennant Group3.6977 of 5 stars$31.62+1.4%$38.25+21.0%+130.9%$1.09B$652.30M45.855,791Positive News Related Companies and Tools Related Companies ADUS Competitors WGS Competitors TDOC Competitors NHC Competitors FTRE Competitors VRDN Competitors CDNA Competitors AHCO Competitors AVAH Competitors PNTG Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:FLGT) was last updated on 12/3/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredIs NVDA a sell? Buy this stock instead before Dec 3After months of speculation that Nvidia was "cooling off..." and "running out of steam..." The company is m...Chaikin Analytics | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fulgent Genetics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Fulgent Genetics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
